Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The central nervous system (CNS) is the part of thenervous system consisting of the brain and spinal cord. In this report, we study the drugs for central nervous system disease.
The report details the trend, potential and market size of Drugs for Central Nervous System market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Drugs for Central Nervous Systemmarket, defines the market attractiveness level of Drugs for Central Nervous System market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Drugs for Central Nervous System industry, describes the types of Drugs for Central Nervous System market, the applications of major players and the market size, and deeply analyzes the current situation of the global Drugs for Central Nervous System market and the development prospects and opportunities of Drugs for Central Nervous System industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Drugs for Central Nervous System market in Chapter 13.
By Player:
Johnson & Johnson
Shire
Novartis
Merck
Eli Lilly
Pfizer
AstraZeneca
Teva
Biogen
Otsuka
By Type:
OTC
Rx Drugs
By End-User:
Hospital
Retail Pharmacy
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Drugs for Central Nervous System Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Drugs for Central Nervous System Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Drugs for Central Nervous System Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Drugs for Central Nervous System Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Drugs for Central Nervous System Market Analysis and Outlook to 2022
-
7.1 Global Drugs for Central Nervous System Consumption (2017-2022)
-
7.2 United States Drugs for Central Nervous System Consumption (2017-2022)
-
7.3 Europe Drugs for Central Nervous System Consumption (2017-2022)
-
7.4 China Drugs for Central Nervous System Consumption (2017-2022)
-
7.5 Japan Drugs for Central Nervous System Consumption (2017-2022)
-
7.6 India Drugs for Central Nervous System Consumption (2017-2022)
-
7.7 South Korea Drugs for Central Nervous System Consumption (2017-2022)
8 Region and Country-wise Drugs for Central Nervous System Market Analysis and Outlook to 2028
-
8.1 Global Drugs for Central Nervous System Consumption Forecast (2022-2028)
-
8.2 United States Drugs for Central Nervous System Consumption Forecast (2022-2028)
-
8.3 Europe Drugs for Central Nervous System Consumption Forecast (2022-2028)
-
8.4 China Drugs for Central Nervous System Consumption Forecast (2022-2028)
-
8.5 Japan Drugs for Central Nervous System Consumption Forecast (2022-2028)
-
8.6 India Drugs for Central Nervous System Consumption Forecast (2022-2028)
-
8.7 South Korea Drugs for Central Nervous System Consumption Forecast (2022-2028)
9 Global Drugs for Central Nervous System Market Outlook by Types and Applications to 2022
-
9.1 Global Drugs for Central Nervous System Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global OTC Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Rx Drugs Consumption and Growth Rate (2017-2022)
-
9.2 Global Drugs for Central Nervous System Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Hospital Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Retail Pharmacy Consumption and Growth Rate (2017-2022)
10 Global Drugs for Central Nervous System Market Outlook by Types and Applications to 2028
-
10.1 Global Drugs for Central Nervous System Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global OTC Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Rx Drugs Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Drugs for Central Nervous System Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Hospital Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Retail Pharmacy Consumption Forecast and Growth Rate (2022-2028)
11 Global Drugs for Central Nervous System Import and Export Analysis (Top 5 Countries)
-
11.1 Global Drugs for Central Nervous System Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Drugs for Central Nervous System Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Drugs for Central Nervous System Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Drugs for Central Nervous System Market Competitive Analysis
-
14.1 Johnson & Johnson
-
14.1.1 Johnson & Johnson Company Details
-
14.1.2 Johnson & Johnson Drugs for Central Nervous System Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Johnson & Johnson Drugs for Central Nervous System Product and Service
-
14.2 Shire
-
14.2.1 Shire Company Details
-
14.2.2 Shire Drugs for Central Nervous System Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Shire Drugs for Central Nervous System Product and Service
-
14.3 Novartis
-
14.3.1 Novartis Company Details
-
14.3.2 Novartis Drugs for Central Nervous System Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Novartis Drugs for Central Nervous System Product and Service
-
14.4 Merck
-
14.4.1 Merck Company Details
-
14.4.2 Merck Drugs for Central Nervous System Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Merck Drugs for Central Nervous System Product and Service
-
14.5 Eli Lilly
-
14.5.1 Eli Lilly Company Details
-
14.5.2 Eli Lilly Drugs for Central Nervous System Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Eli Lilly Drugs for Central Nervous System Product and Service
-
14.6 Pfizer
-
14.6.1 Pfizer Company Details
-
14.6.2 Pfizer Drugs for Central Nervous System Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Pfizer Drugs for Central Nervous System Product and Service
-
14.7 AstraZeneca
-
14.7.1 AstraZeneca Company Details
-
14.7.2 AstraZeneca Drugs for Central Nervous System Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 AstraZeneca Drugs for Central Nervous System Product and Service
-
14.8 Teva
-
14.8.1 Teva Company Details
-
14.8.2 Teva Drugs for Central Nervous System Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 Teva Drugs for Central Nervous System Product and Service
-
14.9 Biogen
-
14.9.1 Biogen Company Details
-
14.9.2 Biogen Drugs for Central Nervous System Sales, Price, Value and Gross Profit (2017-2022)
-
14.9.3 Biogen Drugs for Central Nervous System Product and Service
-
14.10 Otsuka
-
14.10.1 Otsuka Company Details
-
14.10.2 Otsuka Drugs for Central Nervous System Sales, Price, Value and Gross Profit (2017-2022)
-
14.10.3 Otsuka Drugs for Central Nervous System Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Drugs for Central Nervous System
-
Figure Drugs for Central Nervous System Picture
-
Table Global Drugs for Central Nervous System Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Drugs for Central Nervous System Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Drugs for Central Nervous System Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Drugs for Central Nervous System Consumption by Country (2017-2022)
-
Figure United States Drugs for Central Nervous System Consumption and Growth Rate (2017-2022)
-
Table Europe Drugs for Central Nervous System Consumption and Growth Rate (2017-2022)
-
Figure China Drugs for Central Nervous System Consumption and Growth Rate (2017-2022)
-
Figure Japan Drugs for Central Nervous System Consumption and Growth Rate (2017-2022)
-
Figure India Drugs for Central Nervous System Consumption and Growth Rate (2017-2022)
-
Figure South Korea Drugs for Central Nervous System Consumption and Growth Rate (2017-2022)
-
Figure Global Drugs for Central Nervous System Consumption Forecast by Country (2022-2028)
-
Figure United States Drugs for Central Nervous System Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Drugs for Central Nervous System Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Drugs for Central Nervous System Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Drugs for Central Nervous System Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Drugs for Central Nervous System Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Drugs for Central Nervous System Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global OTC Consumption and Growth Rate (2017-2022)
-
Figure Global Rx Drugs Consumption and Growth Rate (2017-2022)
-
Figure Global Hospital Consumption and Growth Rate (2017-2022)
-
Figure Global Retail Pharmacy Consumption and Growth Rate (2017-2022)
-
Figure Global OTC Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Rx Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hospital Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Retail Pharmacy Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Drugs for Central Nervous System Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Drugs for Central Nervous System Export by Region (Top 5 Countries) (2017-2028)
-
Table Johnson & Johnson (Foundation Year, Company Profile and etc.)
-
Table Johnson & Johnson Drugs for Central Nervous System Sales, Price, Value and Gross Profit (2017-2022)
-
Table Johnson & Johnson Drugs for Central Nervous System Product and Service
-
Table Shire (Foundation Year, Company Profile and etc.)
-
Table Shire Drugs for Central Nervous System Sales, Price, Value and Gross Profit (2017-2022)
-
Table Shire Drugs for Central Nervous System Product and Service
-
Table Novartis (Foundation Year, Company Profile and etc.)
-
Table Novartis Drugs for Central Nervous System Sales, Price, Value and Gross Profit (2017-2022)
-
Table Novartis Drugs for Central Nervous System Product and Service
-
Table Merck (Foundation Year, Company Profile and etc.)
-
Table Merck Drugs for Central Nervous System Sales, Price, Value and Gross Profit (2017-2022)
-
Table Merck Drugs for Central Nervous System Product and Service
-
Table Eli Lilly (Foundation Year, Company Profile and etc.)
-
Table Eli Lilly Drugs for Central Nervous System Sales, Price, Value and Gross Profit (2017-2022)
-
Table Eli Lilly Drugs for Central Nervous System Product and Service
-
Table Pfizer (Foundation Year, Company Profile and etc.)
-
Table Pfizer Drugs for Central Nervous System Sales, Price, Value and Gross Profit (2017-2022)
-
Table Pfizer Drugs for Central Nervous System Product and Service
-
Table AstraZeneca (Foundation Year, Company Profile and etc.)
-
Table AstraZeneca Drugs for Central Nervous System Sales, Price, Value and Gross Profit (2017-2022)
-
Table AstraZeneca Drugs for Central Nervous System Product and Service
-
Table Teva (Foundation Year, Company Profile and etc.)
-
Table Teva Drugs for Central Nervous System Sales, Price, Value and Gross Profit (2017-2022)
-
Table Teva Drugs for Central Nervous System Product and Service
-
Table Biogen (Foundation Year, Company Profile and etc.)
-
Table Biogen Drugs for Central Nervous System Sales, Price, Value and Gross Profit (2017-2022)
-
Table Biogen Drugs for Central Nervous System Product and Service
-
Table Otsuka (Foundation Year, Company Profile and etc.)
-
Table Otsuka Drugs for Central Nervous System Sales, Price, Value and Gross Profit (2017-2022)
-
Table Otsuka Drugs for Central Nervous System Product and Service
-
